SEC 13F Intelligence

Michelson Medical Research Foundation, Inc. / RTO

Michelson Medical Research Foundation, Inc.’s Rentokil Initial PLC Position

Does Michelson Medical Research Foundation, Inc. own Rentokil Initial PLC (RTO)? Not currently — the last reported position was 457.8K shares worth $11M in Q2 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$11M
Q2 2025
Shares
457.8K
% of Portfolio
+10.54%
Quarters Held
4
position exited

Position History RTO

Reported value by quarter
Q3 ’24: $4MQ3 ’24Q4 ’24: $5MQ4 ’24Q1 ’25: $11MQ1 ’25Q2 ’25: $11MQ2 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2025457.8K$11M+10.54%
Q1 2025500.0K$11M+9.58%
Q4 2024180.0K$5M+3.82%
Q3 2024180.0K$4M+3.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Michelson Medical Research Foundation, Inc.’s full portfolio or all institutional holders of RTO.